Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

A Woodstock Moment for Malaria

Excuse me if I chuckle at the analogy between a 3-day meeting on malaria and Woodstock, or even the Oscars. I mean really, as one of my colleagues says, how could Woodstock measure up to malaria? There has been a certain amount of ceremony - starting with the stagey introductions that emanate from behind the tall curtains - and a rock-star build-up to the presence of Bill and Melinda Gates at the meeting this morning.

Should All Vertical Programs Just Lie Down?

"Vertical" health programs are once again unfashionable, subject to a blistering set of critiques from all manner of experts - some of whom were instrumental, just a few short years ago, in promoting them.

A Global Call for Informed Decisionmaking on HPV Vaccines

HPV vaccines are the first of several new preventive technologies aimed at adolescent girls - an entirely new market that poses a series of unique policy and finance challenges to developing country governments and donors. As a result, decisions about HPV introduction have been so closely linked to the eventual availability of AIDS vaccines and microbicides that the conversation has largely shifted away from talk of cost-effectiveness and public health benefits (e.g.

Insuring the Flu: Vaccines for All?

Reuters recently reported that the global health community is beginning to explore potential insurance mechanisms and risk management products to finance pandemic flu vaccines for developing countries, in addition to a new vaccine stockpile supported by GSK and other manufacturers:

10 African Countries Consider "Paying for Performance" in Health

Strengthening health systems to improve utilization, quality and efficiency of service delivery is a challenge that continues to stump smart people working in public health and development. A promising and increasingly prominent solution is paying health workers, health facilities and households to behave in ways that generate better health results. A few months ago, Ruth Levine reported on an upcoming workshop that would convene teams of African implementers and researchers to develop performance-based incentive schemes within their own health systems. Below, Rena Eichler reports back on her experiences from that workshop.

On the Road to Universal Access: Are We There Yet?

Treating people seemed relatively easy compared to existing prevention efforts when ARVs emerged on the AIDS scene. Largely due to activist efforts, drugs were quickly produced in large enough quantities and eventually at an affordable price for donors to provide to millions of people in the developing world. Expectations for rapid scale up of treatment programs were hopefully high, but hopelessly unrealistic.